[1] Finucane BT,Santora FA.eds.Principle of airway management[M]. 3rd. New York:Spinger-Verlag,2003:93-113. [2] 彭玲,傅少雄.右美托咪啶用于全麻患者清醒气管插管的效果[J].中华麻醉学杂志,2010,30(11):1398-1399. [3] Beers R,Camporesi E.Remifentanil update:clinical science and utility[J].CNS Drugs,2004,18(15):1085-1104. [4] Puchner W,Egger P,Puhringer F,et al.Evaluation of remifentanil as single drug for awake fiberoptic intubation[J].Acta Anaesthesiologica Scandinavica,2002,46(4):350-354. [5] 中华医学会麻醉学分会.困难气道管理专家共识[J].临床麻醉学杂志,2009,25(3):200-203. [6] Maroof M,Khan RM,Jain D,et al.Dexmedetomidine is a usefull adjunct for awake intubation[J].Can J Anaesth,2005,52(7):776-777. [7] Tsai CJ,Chu KS,Chen TI,et a1.A comparison of the effectiveness of dexmedetomidine versus propofol targetcontrolled infusion for sedating during fibreoptic nasotracheal intubation[J].Anaesthesia,2010,65(3):254-259. [8] O'Hare R,McAtamney D,Mirakhur RK,et a1.Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia[J].Br J Anaesth,1999,82(3):283-285. [9] 许亚超,薛富强.瑞芬太尼抑制患者清醒气管插管反应的半数有效剂量[J].中华麻醉学杂志,2008,28(10):873-876. [10] 宿亚敏. 瑞芬太尼靶控输注用于清醒气管插管30例[J].临床医药,2011,20(11):56-57. |